• Clip News: Display Concepts - Clip Distributor Completes a Stunning Exhibition Stand Design  Read More...
  • Clip News: Clip Stand confirmed at Institute of Fundraising November 23rd & 24th, a must for all Charity contacts, come & see us on stand number two!
  • Clip News: Just finalised a stand at World Travel Market for a long standing Clip user!
  • Clip News: The team at Clip are developing,maufacturing and installing a new contemporary brand awareness and hospitality area at its world leading leisure industry clients UK Headquarters
  • Customer comments: Great to hear this from one of our customers "I have not forgotten how useful Clip and your good self were whilst I was at Tensar/Carborundum”.  Our hardworking team did themselves credit...
  • Clip News: Finalised site plans for Shanghai Motor Show, penultimate leg of Saint-Gobains global event programme for 2011, great first year working with this new partner’
  • Clip News: Discussing brief for 12m x 10m stand with Clip in-house design dept for DUK March 2012
  • Clip News: Finalised plans for small stand and external branding at British Free Range Egg Producers Association Conf November 2011
  • Have you seen our online shop for exhibition supplies? View it here...
  • Clip News: Supporting a long standing client again at the Inter Airport Show in Munich by building a 60 square metre stand

Exhibition Stands News

Sanofi-Aventis to acquire BiPar Sciences

15 Apr 2009

Pharmaceutical firm Sanofi-Aventis has announced it is taking steps to reinforce its oncology research and development portfolio by acquiring BiPar Sciences.

The parent company''s chief executive Christopher A Viehbacher explained the company was determined to improve and expand its operations by merging with the privately-held business.

He said the move shows an attempt to look at new approaches to strengthening its pipeline.

"This acquisition illustrates our strong commitment to oncology to provide patients, physicians and public health stakeholders with breakthrough medicines addressing unmet medical needs," Mr Viehbacher added.

One of the leaders in the DNA field, the Paris-based firm uses Poly ADP-Ribose Polymerase inhibitors to target and kill cancer cells.

The move is subject to the acceptance of the Federal Trade Commission and is expected to be completed by the end of the second quarter of 2009.

It comes a week after Sanofi-Aventis agreed to take over Brazilian Firm Medley.
ADNFCR-2086-ID-19122918-ADNFCR